Lumify

Active Ingredient(s): Brimonidine Tartrate
FDA Approved: * December 22, 2017
Pharm Company: * BAUSCH AND LOMB INC
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lumify Overview

Brimonidine is a medication used to treat open-angle glaucoma, ocular hypertension, and rosacea.[1][2] In rosacea it improves the redness.[2] It is used as eye drops or applied to the skin.[1][2] Common side effects when used in the eyes include itchiness, redness, and a dry mouth.[1] Common side effects when used on the skin include redness, burning, and headaches.[2] More signific...

Read more Lumify Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brimonidine

Recent Lumify Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Brimonidine Tartrate
  • Drops: 0.2%
  • Gel: 0.33%
  • Solution: 0.15%, 0.2%
  • Solution/drops: 0.025%, 0.1%, 0.10%, 0.15%, 0.2%, 0.20%, 0.5%, 0.50%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Brimonidine Tartrate or a similar ingredient: (8 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA